Healthcare -
Biotechnology - NASDAQ - US
$ 6.27
0.642 %
$ 428 M
Market Cap
-3.15
P/E
EYPT - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities EYPT - EyePoint Pharmaceuticals, Inc.
187 M
LAST VALUE
-7.13%
2 YEAR CAGR
25.26%
5 YEAR CAGR
44.64%
10 YEAR CAGR